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SUMMARY
1. The general term ‘nanoparticle’ (NP) is used to define any
particle less than 100 nm in at least one dimension and NPs are
generally classified as natural, anthropogenic or engineered in
origin. Anthropogenic, also referred to as ‘ultrafine’ particles
(UFPs), are predominately combustion derived and are character-
ized by having an equivalent spherical diameter less than 100 nm.
2. These particles, considered to be ‘combustion-derived
nanoparticles’ (CDNPs), are of toxicological interest given their
nanosized dimensions, with properties not displayed by their
macroscopic counterparts.
3. The pulmonary deposition efficiency of inhaled UFPs,
along with their large surface areas and bound transition metals,
is considered important in driving the emerging health effects
linked to respiratory toxicity.
4. The toxicology of CDNPs is currently used to predict the
health outcomes in humans following exposure to manufactured
NPs. Their similar physicochemistry would suggest similar adverse
health effects (i.e. pulmonary (and perhaps cardiac) toxicity). As
such, it is essential to fully understand CDNP nanotoxicology in
order to minimize occupational and environmental exposure.
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PARTICULATE MATTER (PM10 AND PM2.5) 
AND NANOPARTICLES
Epidemiological and toxicological research suggests that ‘small’,
ambient, airborne particles cause ‘big’ health effects in people with pre-
existing cardiopulmonary diseases.1,2 These so-called ‘ultrafine
particles’ (UFPs) are in the nanometer size range (1 ¥ 10–9 m) and are
considered to be nanosized particles (NPs). They are usually un-
intentionally produced byproducts of processes involving industrial,
combustion and automobile activities (Fig. 1). The airborne par-
ticulate matter (PM) produced from these sources contains particles
in three size categories, which are collectively referred to as PM10.
The metric PM10 is defined as particulate matter less than 10 mm in
aerodynamic diameter, where particles less than 0.1 mm are regarded
as being ‘ultrafine’ (UF), those between 0.1 and 2.5 mm are ‘fine’
in size and particles that are 2.5–10 mm are referred to as ‘coarse’.
Most of the particle mass is found in the fine or PM2.5 size range
and the largest number of particles is observed in the UF category.
Matter in the PM10 category is highly heterogeneous in nature and
it would be futile to define its mineralogy or structure. However, the
composition of PM10 is controlled by factors such as weather,
continental-scale influences and regional and local influences.
In urban and industrial areas, PM10 is dominated by road transport,
industrial and construction particles, whereas in rural areas it is
mainly composed of biogenic (e.g. pollen grains, fungal spores, plant
material) and fugitive dust particles from erosion. Consequently,
UFPs may possess a wide range of physicochemical properties (e.g.
surface metal contaminants and aromatic compounds) owing to
different emission sources and geographical locations. From a
toxicological point of view, the most important class of these
so-called NPs is that derived from traffic exhaust, which accounts
for up to 80% of human exposure.2,3
Human exposure to NPs has increased markedly over the past
century due to anthropogenic activities dominated by coal and diesel
oil fuel combustion. Moreover, the advent of nanotechnology will
most likely contribute yet another source of aerial PM pollution via
engineered nanomaterials. Consequently, this rapidly progressing
field has given rise to a new division of toxicology, namely ‘nano-
toxicology’, which involves the safety evaluation of engineered
nanostructures and nanodevices.
Current and historical epidemiological and toxicological investi-
gations with airborne UFPs4 are viewed as the basis for the expand-
ing field of nanotoxicology and a number of key endocytotic and
biokinetic concepts have been identified from the results of these
studies: (i) the major portal of entry into the human body for NPs
is via inhalation into the respiratory system (Fig. 2); (ii) NPs can
transcytose epithelial/endothelial cells into the systemic circulation
to reach sensitive target tissues (Fig. 3a); (iii) NPs are capable
of generating reactive oxygen species (ROS), which have been
linked to inflammatory lung diseases (Fig. 3b); and (iv) invasion
of the systemic circulation by NPs has been implicated in cardiac
dysfunctions (Fig. 3c,d).
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PARTICLE PHYSICOCHEMISTRY
Manufactured nanoparticles
The principal patterns of particle endocytosis and biokinetics are
largely dependent on their physicochemical properties, which include
particle size and distribution, agglomeration state, shape, crystallinity,
chemical composition, surface area (SA), surface chemistry, surface
charge and porosity.1,2 Nanoparticles have been broadly defined as
microscopic particles with dimensions less than 100 nm; however,
‘manufactured’ NPs are more precisely defined as having one dimension
less than 100 nm (Fig. 4). Many nanoparticles, whether manufactured,
combustion derived or natural (e.g. emissions from volcanic activity,
earth erosions and sand storms), are prone to rapid agglomeration,
forming larger ‘particles’ with dimensions much greater than 100 nm.
These are termed ‘nano-structured particles’ (NSP), as long as their
activity is governed by their nanoparticle components (Fig. 1). For
example, an agglomerate of a TiO2-manufactured NSP (Fig. 4b),
forming a single NSP much larger than 100 nm in diameter, has
significantly greater biological activity than a single crystal TiO2
particle of the same diameter.2 The physicochemical properties
of NPs have been associated with pulmonary toxicity in humans.5
Fig. 1 Field emission scanning electron
micrographs of combustion-derived
nanoparticles: (a) large soot nano-
structured particle, lying on a dense
bed of soot nanoparticles; (b) detail
of the flocculated (‘bunch-of-grapes’)
structure of soot; (c) carbon black
sample denoting a mixed population
of fine and nanosized particles; (d)
carbon black sample from a population
of strictly nanoparticles; (e) urban
nanoparticles collected from Cardiff,
Wales, UK; (f ) residual oil fly ash
(ROFA) particles.
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COMBUSTION-DERIVED NPs
Combustion-derived NPs (CDNPs), such as diesel exhaust particles
(DEP), carbon black (CB) and fly ash (FA; e.g. residual oil fly ash
(ROFA)) are all occupational and environmental hazards (Fig. 1).2
For this class of poorly soluble particles, their large SA alone is
enough to drive lung inflammation; when a given mass of material
is divided into an increasing number of units, the total SA of those
units increases. The CDNPs are ‘primary’ emitted particles in the
sense that they arise directly from combustion processes. However,
as they age, and when mixed with other ambient pollutants, their
chemical composition can change. Their chemistry is derived from
the combustion and pyrolysis processes, whereby combustion
concentrates transition metals and pyrolysis generates organic
compounds, along with elemental organic carbon particles.
Diesel exhaust particles
Diesel exhaust particles account for up to 80% of the mass of PM10
collected in urban areas (Figs 1a,b,4c). They differ from soot,
in the form of CB, because they contain toxic metals and organics
and this, in combination with their large SA, drives the production
of ROS (Fig. 5).2,3 For the formation of ROS, the large SA presents
Fig. 3 The fate of nanoparticles in
the human body: (a) translocation into
the brain via transcytosis into the cells
of the nasal and tracheo-bronchial
epithelia; (b) phagocytosis by
macrophages within the mucociliary
escalator and resultant reactive
oxygen species generation; (c) evasion
of defence mechanisms and
translocation into the systemic
circulation (blood); (d) translocation
into the blood and disruption of
atheromatous plaques.
Fig. 2 Diagrammatic representation of the translocation patterns of coarse
(inhalable), fine (thoracic) and ultrafine/nanosized (respirable) particles in
the human respiratory system.
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an opportunity for dissolution of soluble species and provides a
substrate on which catalytic chemistry can occur.
Soot particles are typically organized as chain-like aggregations
of primary, spherical particles. The aggregations can consist of just
a few through to many thousands of spheres. The mechanism of soot
formation involves an initial particle nucleation from fuel pyrolysis
forming polycyclic aromatic hydrocarbons (PAHs), addition to the
nucleus by gas molecules, coagulation by particle–particle collisions,
removal of functional groups and dehydrogenation and structural
rearrangements of the condensed material.2 The core of the sphere,
typically with a diameter of approximately 10 nm, is composed of
concentrically piled, thermodynamically unstable turbostratic, carbon
networks. The consequence of this organization is a potential to hold
materials such as volatile organic compounds (VOCs), sulphur and
transition metals in the large intranetwork spaces.2 The outer part of
the sphere is better ordered, more stable and composed of graphitic
microcrystallites of orientated carbon sheets. Vapor-phase hydro-
carbons condense on the sphere surface during the cooling stage
of the combustive process. Many toxicological studies have shown
that chemically ‘pure’ soot particles, such as CB, have significantly
less bioreactivity than common, urban PM10 soot particles generated
by diesel engines.2
Carbon black particles
Carbon black is a low-solubility particle (Fig. 1c,d) produced indus-
trially from the incomplete thermal decomposition of hydrocarbons.
This process is controlled to achieve predefined and reproducible
Fig. 4 Transmission electron micro-
graphs of manufactured and combustion-
derived nanoparticles (anthropogenic):
(a) ‘Cab-O-sil’ (Cabot, Cardiff, UK);
(b) TiO2 (Sigma, Poole, UK); (c) diesel
exhaust particles (Cardiff, Wales, UK).
The manufactured and anthropogenic
particles share a common morphological
organization characterized by chain-
like aggregates of spherical particles.
Fig. 5 The common molecular pathways of combustion-derived
nanoparticles (CDNPs). MAPK, Mitogen-activated protein kinase; NF-kB,
nuclear factor-kB; AP-1, activator protein-1.
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particle sizes and properties suitable for a diverse range of industrial
applications, such as photocopier toner. Carbon black exhibits the
same behaviour as DEP, in that its spherical particles aggregate into
agglomerates that can be highly respirable. In long-term studies, CB
has been shown to be a carcinogen, but the phenomenon of ‘particle
effect’ (i.e. large SA drives toxicity)6 plays a likely role in this
outcome (Fig. 5).3
The acute effects of CB exposure in humans are similar to effects
caused by other insoluble particles. In general, long-term occupational
exposure to CB may cause slight radiological changes; workers may
develop chronic bronchitis and a slight reduction in lung func-
tion. These effects can be attributed to a non-specific irritant effect
of heavy dust exposure. Fibrosis has been reported in early studies
under excessive dust conditions, but epidemiological studies have
not established excess human cancer risk with CB exposure.7–9
Fly ash particles
Fly ash is a generic term for particulate matter from mineral and
metal contaminants of organic fuels. The two main groups of FA
are ROFA (from liquid fuel) and solid fuel. The ROFA contains
transition metals, sulphates and acids incorporated into a particulate
carbonaceous core. The solubility and bioavailability of the transi-
tion metals associated with these particles is of interest. Occupational
exposure resulting in adverse respiratory health effects in humans
has been recorded.10–12
Fly ash produced by coal or waste combustion is derived from
mineral, sulphur or other contaminants in the fuel. Especially in
industrial towns, this type of FA is a common air-borne component.
It is composed of predominantly spherical or subspherical glassy
particles (60–90% glass), from the melting of the minerals. Most
FA is found in the PM10–PM2.5 coarse fraction. The spheres are either
solid or hollow and broken fragments of the spheres are commonly
collected. Fly ash particles generated by the metal industries often
have characteristic granular or spherical morphologies.
Toxicological studies using unfractionated FA from solid fuels
have shown it to be of low toxicity, but its bioavailable metals have
been implicated in ROS generation (Fig. 5).3,13,14 Upon fractionation
of FA, the NSPs exhibited increased potency compared with its fine
and coarse fractions.14 The NSP fraction contained carbonaceous
aggregates (20–50 nm) and surface-bound metals (approximately
10 nm particles of Fe, Al and Ti). In general, FA has a low metal
concentration and it is believed that the bioreactive NSP fraction is
due to increased SA, which allows redox reactions to take place. This
is a similar mechanism to that proposed for CB and, hence, in the
absence of soluble transition metals and VOCs associated with
a particle, a large SA can drive the inflammation that causes a variety
of lung and heart diseases.
NANOPARTICLE TOXICOLOGY
Given that inflammation is a common response to inhalation of
CDNPs, in both animals and human epidemiology, there is now a
unifying hypothesis for their toxicity.3 They have a generic ability
to cause inflammation via oxidative stress and activation of redox-
sensitive transcription factors (i.e. mitogen-activated protein kinase
and nuclear factor-kB; Fig. 5)15–17 that can lead to the observed
adverse health effects (e.g. fibrosis, chronic inflammatory lung dis-
ease, cancer). The physicochemical properties that drive these effects
differ greatly between these exemplar CDNPs. That is, DEP have a
soluble component and release transition metals or organics as their
primary pro-inflammatory mechanisms, a combination of large
SA and soluble metals determine the pro-oxidant activity of FA, and
the SA effect alone is responsible for the bioreactivity of CB
particles. When the transition metals and PAHs interact with the
lining fluids of the lung, they undergo cycling redox reactions that
produce ROS (e.g. superoxide anion, hydroxly radical).3
The mechanisms involved in particle-induced genotoxicity remain
poorly understood, because the particles are uniquely complex owing
to their physicochemical characteristics. There is some piecemeal
evidence that DEP,19,19 CB21,21 and FA23,23 are carcinogenic in humans
(Fig. 6).3 Diesel exhaust particles consist of a carbon core with
adsorbed PAHs and transition metals.24 Genotoxicity may be induced
by the direct interaction of PAHs, which are known to cause DNA
adducts.25,26 Alternatively, the transition metals may induce ROS,
which results in DNA strand breakage.27 Carbon black is generally
devoid of adsorbed organics and metals and, thus, its genotoxicity
is most likely an effect of the particle overload phenomenon,
but some research has revealed the formation of the oxidative
DNA lesion 8-hydroxydeoxyguanosine (8-OH-dG).20,21,28 Studies
investigating the genotoxicity of FA have determined a role for par-
ticle size and iron release leading to radical generation and oxidative
stress.29
A few key mechanistic hypotheses (Fig. 7)5 have been advanced
to explain the associations observed in the epidemiological studies
and have provided the foundation upon which current toxicological
research is now focused.
1. Cardiac effects are a consequence of pulmonary inflammation,
which interferes with coagulability and stability of atheromatus plaques.
2. Inhalation of particles triggers pulmonary reflexes that disrupt
cardiac rhythm.
Fig. 6 Suspected genotoxic pathways of combustion-derived nanoparticles: (a) diesel exhaust particles; (b) carbon black; and (c) fly ash. 8-OH-dG, 8-
hydroxydeoxyguanosine.
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3. Lung inflammation is a consequence not of the mass, but of the
number of particles.
The first hypothesis suggests that inhaled particles, especially
NPs, establish pulmonary inflammation that triggers changes in the
control of blood clotting.5,30–34 The concomitant changes in chemical
factors in the blood can affect the stability of the atheromatus plaques
(fatty deposits) found in the walls of arteries that supply blood to
the muscle of the heart itself. If this is true, then a link between
inhalation of particles and the likelihood of, for example, heart
attacks will have been established.
The UFPs/NPs could also have effects on cardiac physiology if
they gain access to the bloodstream (Fig. 7).5 The possibility of
transfer of particles by blood to the heart causing a direct effect
has been proposed.31–34 The circulating particles may interact with
vascular endothelium/atherosclerotic lesions, causing local oxidative
stress that could destabilize plaques, setting off a chain reaction
(rupture, thrombosis) with resultant acute coronary syndrome.5
Furthermore, particles may interact with circulating coagulation
factors to promote thrombogenesis. To date, there are no published
data demonstrating that the CDNP gain access to the blood in humans.
The second hypothesis suggests that inhaled particles may act
directly, or perhaps as a result of, a local inflammatory response on
nerve endings in the walls of the airways throughout the respiratory
system.5 Activation of such receptors initiates changes in the auto-
nomic control of the heart and, thus, changes in the heart’s rhythm
(e.g. fatal arrhythmias). This hypothesis links with the one above and,
hence, inflammation may be involved in the early stages of both.5
A third and final theory purports that lung inflammation is a con-
sequence not of the mass, but of the number of particles, particularly
those in the UF size range.5 This hypothesis has the potential to
explain both short-term morbidity and also longer-term athero-
genesis. The human lung is subjected to daily low mass concentrations
of particles, but high number concentrations.35 It is estimated5 that
on a so-called ‘low pollution’ day (over 24 h), an adult human will
inhale approximately 200 billion particles, half of which will be
deposited in the lung, without apparent harm. These huge numbers
of particles are contained in a very small mass (400 mg). During
pollution episodes, where the average particle mass rises to
50 mg/m3, the mass of particles inhaled associated with adverse
cardiac effects may contain 2000 billion particles. It is therefore
self-evident that the mass does not represent the number of particles.
CONCLUSIONS
The CDNPs are a fact of modern life and contribute substantially to
poor air quality, especially in the urban environment.36 The lung is
the primary portal of entry into the human body for CDNPs, but it
is the heart that is the final sensitive target organ. The CDNPs are
unified by their combustive origins, small size and universal mechan-
ism of injury and common pathways of translocation in the body.
Consequently, they should be recognized as a cardiopulmonary hazard.
Fig. 7 Principal hypotheses of the cardiopulmonary toxicity of nanoparticles: pulmonary inflammation, pulmonary reflexes and blood-borne combustion-
derived nanoparticles (CDNP). PM, particulate matter.
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